AOTI, Inc. (AOTI) Price & Analysis

Q: What was AOTI, Inc.’s price range in the past 12 months?

AOTI, Inc. lowest share price was 25.00p and its highest was 115.00p in the past 12 months.

Q: What is AOTI, Inc.’s market cap?

AOTI, Inc.’s market cap is £44.67M.

Q: When is AOTI, Inc.’s upcoming earnings report date?

AOTI, Inc.’s upcoming earnings report date is May 04, 2026 which is in 77 days.

Q: How were AOTI, Inc.’s earnings last quarter?

AOTI, Inc. released its earnings results on Sep 22, 2025. The company reported 0p earnings per share for the quarter, the consensus estimate of N/A by 0p.

Q: Is AOTI, Inc. overvalued?

According to Wall Street analysts AOTI, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does AOTI, Inc. pay dividends?

AOTI, Inc. does not currently pay dividends.

Q: What is AOTI, Inc.’s EPS estimate?

AOTI, Inc.’s EPS estimate is <0.01.

Q: How many shares outstanding does AOTI, Inc. have?

AOTI, Inc. has 106,359,160 shares outstanding.

Q: What happened to AOTI, Inc.’s price movement after its last earnings report?

AOTI, Inc. reported an EPS of 0p in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -5.556%.

Q: Which hedge fund is a major shareholder of AOTI, Inc.?

Currently, no hedge funds are holding shares in GB:AOTI

Compare

3 Followers

AOTI Stock Chart & Stats

27.50p

2.00p(1.85%)

At close: Jan 09 4:00 PM EST

27.50p

2.00p(1.85%)

Day’s Range― - ―

52-Week Range25.00p - 115.00p

Previous CloseN/A

Volume150.00K

Average Volume (3M)36.39K

Market Cap

£44.67M

Enterprise Value60.58M

Total Cash (Recent Filing)£9.34M

Total Debt (Recent Filing)£8.92M

Price to Earnings (P/E)―

Beta0.39

Next Earnings

May 04, 2026

EPS Estimate

<0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding106,359,160

10 Day Avg. Volume30,736

30 Day Avg. Volume36,392

Financial Highlights & Ratios

PEG Ratio-0.28

Price to Book (P/B)8.47

Price to Sales (P/S)2.53

P/FCF Ratio-18.81

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth And Gross Margin ExpansionSustained top-line growth combined with a dramatic gross margin improvement implies stronger product-market fit and scalable unit economics. Over 2–6 months this supports reinvestment in R&D and sales, improving competitive positioning and long-term gross-profit resilience.

Improved Capital StructureA move to positive equity and a materially higher equity ratio materially reduces solvency risk and interest burden. This lasting improvement enhances financial flexibility to fund growth initiatives, absorb shocks, and pursue partnerships without immediate refinancing pressure.

Recurring Revenue And Strategic PartnershipsRecurring service and maintenance contracts create predictable revenue and higher customer retention, while strategic partnerships expand distribution and co-development capabilities. These durable revenue characteristics support more stable cash flows and scaled market penetration.

Bears Say

Persistent UnprofitabilityOngoing net losses erode retained capital and require external funding to sustain growth. Over months this limits the firm's ability to self-finance expansion, increases dilution or debt risk, and challenges the transition from margin improvements to consistent net profitability.

Weak Cash Flow ConversionNegative operating and free cash flow indicate the business struggles to convert revenues into liquid resources. This structural cash conversion weakness heightens liquidity risk, forces reliance on external financing, and constrains sustainable investment in product and sales capacity.

Reliance On Financing And Leverage HistoryAlthough leverage fell in 2024, a history of high liabilities and recent dependence on financing imply ongoing funding risk. In adverse conditions this can lead to costly refinancing, restrictive covenants, or equity dilution, limiting strategic flexibility over the medium term.

AOTI, Inc. News

AOTI’s Innovative Approach to Treating Venous Leg Ulcers: A Clinical Study Update

AOTI, Inc. (($GB:AOTI)) announced an update on their ongoing clinical study. The clinical study titled A Multi-national, Prospective,...

4M ago

AOTI

AOTI, Inc. Strengthens Brokerage Team with New Appointment

AOTI, Inc. ( ($GB:AOTI) ) has shared an update. AOTI, Inc. has appointed Panmure Liberum Limited as a...

4M ago

AOTI, Inc. Reports Strong H1 2025 Revenue Growth Amidst US Healthcare Challenges

AOTI, Inc. ( ($GB:AOTI) ) has issued an announcement. AOTI, Inc. reported a 20.9% increase in revenue for...

5M ago

AOTI, Inc. to Release Interim Results and Host Investor Meetings

AOTI, Inc. ( ($GB:AOTI) ) has shared an update. AOTI, Inc. has announced the release of its interim...

5M ago

AOTI’s TWO2® Therapy Gains NICE Recommendation and NHS Framework Inclusion

AOTI, Inc. ( ($GB:AOTI) ) just unveiled an announcement. AOTI, Inc. announced that its Topical Wound Oxygen (TWO2®)...

6M ago

AOTI, Inc. Director Increases Stake with Significant Share Purchase

AOTI, Inc. ( ($GB:AOTI) ) has shared an announcement. AOTI, Inc. announced that Richard Cotton, the Senior Independent...

7M ago

AOTI CFO Increases Stake with Significant Share Purchase

AOTI, Inc. ( ($GB:AOTI) ) has provided an update. AOTI, Inc. announced that its Chief Financial Officer, Mr....

7M ago

AOTI, Inc. Reports Strong H1 2025 Growth Amidst US Healthcare Challenges

AOTI, Inc. ( ($GB:AOTI) ) just unveiled an announcement. AOTI, Inc. announced a trading update for the first...

7M ago

AOTI, Inc. Secures California Medicaid Provider ID, Expanding Market Access

AOTI, Inc. ( ($GB:AOTI) ) has issued an update. AOTI, Inc. has been awarded a new Provider ID...

7M ago

AOTI, Inc. Announces Successful AGM Outcomes and Leadership Changes

AOTI, Inc. ( ($GB:AOTI) ) just unveiled an announcement. AOTI, Inc. announced the results of its Annual General...

8M ago

AOTI FAQ

What was AOTI, Inc.’s price range in the past 12 months?

AOTI, Inc. lowest share price was 25.00p and its highest was 115.00p in the past 12 months.

What is AOTI, Inc.’s market cap?

AOTI, Inc.’s market cap is £44.67M.

When is AOTI, Inc.’s upcoming earnings report date?

AOTI, Inc.’s upcoming earnings report date is May 04, 2026 which is in 77 days.

How were AOTI, Inc.’s earnings last quarter?

AOTI, Inc. released its earnings results on Sep 22, 2025. The company reported 0p earnings per share for the quarter, the consensus estimate of N/A by 0p.

Is AOTI, Inc. overvalued?

According to Wall Street analysts AOTI, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AOTI, Inc. pay dividends?

AOTI, Inc. does not currently pay dividends.

What is AOTI, Inc.’s EPS estimate?

AOTI, Inc.’s EPS estimate is <0.01.

How many shares outstanding does AOTI, Inc. have?

AOTI, Inc. has 106,359,160 shares outstanding.

What happened to AOTI, Inc.’s price movement after its last earnings report?

AOTI, Inc. reported an EPS of 0p in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -5.556%.

Which hedge fund is a major shareholder of AOTI, Inc.?

Currently, no hedge funds are holding shares in GB:AOTI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

AOTI, Inc.

AOTI, Inc. engages in the development and sale of medical solutions for chronic wounds. Its products include the Topical Wound Oxygen (TWO2) Therapy and the NEXA NPWT (negative pressure wound therapy) System. The company was founded by Michael Stephen Griffiths in 2006 and is headquartered in Oceanside, CA.